Frontiers in immunology

Protein in tiny blood particles shows ongoing inflammation and blood clot problems in long COVID

Updated

Abstract

Plasma-derived small extracellular vesicles (SEVs) were analyzed to identify potential biomarkers associated with Long-COVID.

  • Post-acute sequelae of SARS-CoV-2 (PASC), commonly known as Long-COVID, has a diverse range of symptoms affecting millions.
  • The biological mechanisms underlying Long-COVID remain unclear due to its varied clinical presentations.
  • Examining the protein content of SEVs may help in identifying specific biological markers related to Long-COVID.
  • Identifying robust biomarkers is crucial for enhancing understanding of disease mechanisms and improving diagnostic approaches.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free